US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Track this case

Case overview

Case Number:

2:16-md-02724

Court:

Pennsylvania Eastern

Nature of Suit:

Other Statutes: Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

CYNTHIA M. RUFE

Firms

Companies

Government Agencies

Sectors & Industries:

  1. September 10, 2020

    State AGs Say Drugmakers Want To Delay Price-Fixing Trials

    A contingent of state attorneys general suing generic-drug makers over allegations of price-fixing as part of a sprawling multidistrict litigation have said that drugmakers' proposed schedule for four bellwether cases would delay the first trial for months longer than necessary.

  2. August 27, 2020

    Pa. Avoiding Discovery In Price-Fixing Case, Drugmakers Say

    Generic-drug companies accused of orchestrating an industrywide price-fixing scheme have told a Pennsylvania federal court that the state attorney general's office is refusing to hand over documents they need to help mount a defense.

  3. August 12, 2020

    Resellers Say Drug Makers Erred In MDL Bellwether Claim

    A class of indirect resellers who are accusing a group of generic-drug makers of a price-fixing conspiracy in a multidistrict litigation case told a Pennsylvania federal court the drugmakers incorrectly reviewed the record before accusing the resellers of trying to avoid being among the first cases to go to trial.

  4. August 11, 2020

    Drugmakers Say Resellers Trying To Duck Bellwether Status

    A class of indirect resellers accusing a group of generic-drug makers of a price-fixing conspiracy don't want their cases to proceed to trial first in multidistrict litigation, the drugmakers told a Pennsylvania federal court in a Monday filing.

  5. July 14, 2020

    States' Case To Be Bellwether In Generic Drug Price-Fix MDL

    The Pennsylvania federal judge overseeing multidistrict litigation for price-fixing allegations in the generic drug industry has selected a case from state attorneys general to serve as a bellwether along with three private cases centered on individual drugs.

  6. June 10, 2020

    AGs Pile On Generics Cos. With 3rd Price-Fixing Complaint

    State enforcers added more treatments to their price-fixing case against generic-drug makers with a third complaint Wednesday in Connecticut federal court accusing 26 companies and 10 individuals of "rampant" collusion on topically applied treatments.

  7. April 03, 2020

    States' Suit Touted For Bellwether In Generics Price-Fix Case

    Buyers accusing generic-drug makers of price-fixing urged a Pennsylvania federal judge Thursday to accept a special master's recommendation and pick a lawsuit by states as their bellwether conspiracy case, pushing back against Teva Pharmaceuticals' objection to the special master's choice.

  8. March 13, 2020

    States' Case No Bellwether In Price-Fixing MDL, Teva Says

    Teva Pharmaceuticals and other generic-drug makers slammed a special master's recommendation that an antitrust suit by multiple states and territories be the bellwether in Pennsylvania-based multidistrict litigation, arguing it gives an unfair edge to previously filed class actions lodging the same price-fixing claims.

  9. February 28, 2020

    Justices Partially Stay Generic Drug Price-Fixing Discovery

    The U.S. Supreme Court hit the brakes Friday on an expansive part of the discovery order in the massive multidistrict litigation from state attorneys general and private plaintiffs accusing dozens of generic-drug companies of an industrywide price-fixing conspiracy.

  10. February 21, 2020

    Teva Floated As Bellwether In Generic Drug Price-Fixing MDL

    A case brought by 44 state attorneys general against Teva Pharmaceuticals and several other drugmakers should be the bellwether for a massive multidistrict litigation over alleged conspiracies to fix the prices of generic drugs, according to a special master's report Thursday.